| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/07/2013 | US20130058932 Use of pkc-iota inhibitors for the treatment of glioma |
| 03/07/2013 | US20130058930 Subcutaneous needle assisted jet injection administration of methotrexate |
| 03/07/2013 | US20130058926 Method for alleviating and/or preventing skin reddening |
| 03/07/2013 | US20130058922 Pharmaceutical composition containing choline |
| 03/07/2013 | US20130058915 Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| 03/07/2013 | US20130058914 Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof |
| 03/07/2013 | US20130058904 Method and system for treatment of biological tissue |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058892 Pyrimidinyl indole compounds |
| 03/07/2013 | US20130058880 Film forming personal care compositions and methods |
| 03/07/2013 | US20130058876 (trimethoxyphenylamino) pyrimidinyl formulations |
| 03/07/2013 | US20130058871 Method and system for mapping synaptic connectivity using light microscopy |
| 03/07/2013 | US20130058866 N-pyrazole a2a receptor agonists |
| 03/07/2013 | DE112009002721T5 Antiemetisches Pflaster Antiemetic patch |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | DE102011112526A1 Pharmazeutische Zusammensetzung enthaltend carboxylierte Stärke Pharmaceutical composition containing carboxylated starch |
| 03/07/2013 | DE102011112496A1 4-Methylcatecholderivate und deren Verwendung 4-Methylcatecholderivate and their use |
| 03/07/2013 | DE102011112374A1 Temporarily tightening the human skin, preferably on the leg to reduce spider veins comprises applying a short-term cold stimulus on the skin, where the cold stimulus temporarily lowers the temperature of the skin and tightens the skin |
| 03/07/2013 | DE102011112103A1 Composition, useful as antineoplastic drug, comprises a cyclodextrin complex with 12-imidazolyl-1-dodecanol |
| 03/07/2013 | DE102011082013A1 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine 6H-thieno [3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepines |
| 03/07/2013 | CA2878005A1 Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodites to microbiota of firmuctes phylum |
| 03/07/2013 | CA2857374A1 Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity |
| 03/07/2013 | CA2847418A1 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | CA2847328A1 Oral formulations containing hyaluronic acid for sustained drug release |
| 03/07/2013 | CA2847247A1 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
| 03/07/2013 | CA2847235A1 Treatments involving eslicarbazepine acetate or eslicarbazepine |
| 03/07/2013 | CA2847218A1 Formulations and dosage forms of oxidized phospholipids |
| 03/07/2013 | CA2847199A1 Products for anti-inflammation support |
| 03/07/2013 | CA2847075A1 Substituted annellated pyrimidine and the use thereof |
| 03/07/2013 | CA2847066A1 Novel crystal form |
| 03/07/2013 | CA2847017A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | CA2847001A1 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment |
| 03/07/2013 | CA2846752A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | CA2846695A1 Novel soft rock inhibitors |
| 03/07/2013 | CA2846694A1 Novel rock kinase inhibitors |
| 03/07/2013 | CA2846692A1 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines |
| 03/07/2013 | CA2846659A1 Antibacterial compounds and methods for use |
| 03/07/2013 | CA2846655A1 Antibacterial compounds and methods for use |
| 03/07/2013 | CA2846652A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | CA2846603A1 Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| 03/07/2013 | CA2846574A1 Certain chemical entities, compositions, and methods |
| 03/07/2013 | CA2846510A1 Choline salt of an anti - inflammatory substituted cyclobutenedione compound |
| 03/07/2013 | CA2846463A1 Pyrimidines as sodium channel blockers |
| 03/07/2013 | CA2846446A1 Multi-layered release formulation |
| 03/07/2013 | CA2846431A1 Heterocyclic compounds and uses thereof |
| 03/07/2013 | CA2846429A1 Parp inhibitors |
| 03/07/2013 | CA2846413A1 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| 03/07/2013 | CA2846387A1 Methods for treating cardiovascular disorders |
| 03/07/2013 | CA2846384A1 Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 03/07/2013 | CA2846272A1 Pi3k inhibitor for use in the treatment of bone cancer or for preventing metastatic dissemination primary cancer cells into the bone |
| 03/07/2013 | CA2846117A1 Metalloenzyme inhibitor compounds |
| 03/07/2013 | CA2845798A1 Compounds and compositions as pdgfr kinase inhibitors |
| 03/07/2013 | CA2845796A1 Aldh-2 inhibitors in the treatment of addiction |
| 03/07/2013 | CA2845791A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845785A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845753A1 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| 03/07/2013 | CA2845585A1 Decitabine derivative formulations |
| 03/07/2013 | CA2845571A1 Use of organic compound for the treatment of noonan syndrome |
| 03/07/2013 | CA2845459A1 Quinolone compound |
| 03/07/2013 | CA2845169A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845159A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845127A1 Pyrazole compound and pharmaceutical use thereof |
| 03/07/2013 | CA2845108A1 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections |
| 03/07/2013 | CA2844993A1 Platinum anticancer agents |
| 03/07/2013 | CA2844730A1 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/07/2013 | CA2844288A1 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride |
| 03/07/2013 | CA2844128A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/07/2013 | CA2843514A1 (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists |
| 03/07/2013 | CA2833241A1 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections |
| 03/06/2013 | EP2565278A1 Method for the delivery of oligonucleotides |
| 03/06/2013 | EP2565196A1 Prophylactic or therapeutic medication for inner ear disorders |
| 03/06/2013 | EP2565195A1 Peripheral opioid receptor and antagonists and uses thereof |
| 03/06/2013 | EP2565194A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE |
| 03/06/2013 | EP2565193A1 Compositions and methods for inhibition of the JAK pathway |
| 03/06/2013 | EP2565192A1 Anticancer agent |
| 03/06/2013 | EP2565191A1 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy |
| 03/06/2013 | EP2565190A1 Tetrahydrobenzothiophene compound |
| 03/06/2013 | EP2565188A1 Novel photoactivatable paclitaxel derivatives and uses thereof, in particular in cellbiology and cancer treatment |
| 03/06/2013 | EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/06/2013 | EP2565185A1 [5,6]heterocyclic compound |
| 03/06/2013 | EP2565184A1 Therapeutic agent and preventative agent for alzheimer's disease |
| 03/06/2013 | EP2565183A1 Glycine transporter-1 inhibitors |
| 03/06/2013 | EP2565182A1 Novel amide derivative and use thereof as medicine |
| 03/06/2013 | EP2565180A2 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same |
| 03/06/2013 | EP2565178A1 LPA Receptor Antagonists |
| 03/06/2013 | EP2564900A1 C-19 steroids for therapeutic uses |
| 03/06/2013 | EP2564874A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof |
| 03/06/2013 | EP2564873A1 Skin irritation suppressant and transdermal preparation |
| 03/06/2013 | EP2564872A1 Combination of mazindol in the treatment of attention-deficit/hyperactivity disorder |
| 03/06/2013 | EP2564871A1 Therapeutic Agent for Migraine |
| 03/06/2013 | EP2564870A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/06/2013 | EP2564859A1 Hydroxamate compositions |
| 03/06/2013 | EP2564858A1 Composition for the treatment of aesthenopia |
| 03/06/2013 | EP2564857A1 Boron-containing small molecules as anti-inflammatory agents |
| 03/06/2013 | EP2564856A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564855A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564854A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564853A1 Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
| 03/06/2013 | EP2564852A1 Anti-brain-tumor drug |